Reuters logo
BRIEF-Halozyme announces Phase 2 study in advanced pancreas cancer meets key endpoints
January 5, 2017 / 12:19 PM / 8 months ago

BRIEF-Halozyme announces Phase 2 study in advanced pancreas cancer meets key endpoints

Jan 5 (Reuters) - Halozyme Therapeutics Inc :

* Halozyme announces phase 2 study in advanced pancreas cancer meets key endpoints

* Halozyme therapeutics -study achieved its primary endpoint to evaluate and demonstrate a reduction in rate of thromboembolic events in pegph20 arm Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below